PlanQK, the Platform and Ecosystem for Quantum Applications, has successfully raised $15,000,000 in funding. This innovative company, a winner of the German Ministry for Economy and Climate Protection's AI innovation competition, is leading the way in establishing a community of users for quantum applications. Anaqor AG spearheads the consortium, with scientific oversight from the University of Stuttgart's Institute for Architecture of Application System. The impressive list of consortium members includes prestigious entities such as Accenture, Bundesdruckerei, and Fraunhofer FOKUS, among others. With over 100 associated partners, PlanQK is set to revolutionize quantum computing applications across various industries. This funding will further strengthen their position as pioneers in the quantum technology arena, driving innovation and collaboration in this cutting-edge field.
PlanQK Secures $15 Million in Series B Funding to Revolutionize Quantum Applications
Recently funded 路 $15.0M Series bIT Services and IT Consulting
Get the full PlanQK company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
